These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3522559)

  • 1. Tranylcypromine: patterns and predictors of response.
    White K; White J
    J Clin Psychiatry; 1986 Jul; 47(7):380-2. PubMed ID: 3522559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endogenicity and severity on consistency of standard depression rating scales.
    White J; White K; Razani J
    J Clin Psychiatry; 1984 Jun; 45(6):260-1. PubMed ID: 6725218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
    Volz HP; Heimann H; Bellaire J; Laux G; Möller HJ
    Pharmacopsychiatry; 1994 Jul; 27(4):152-8. PubMed ID: 7972347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression.
    Salín-Pascual RJ; Rosas M; Jimenez-Genchi A; Rivera-Meza BL; Delgado-Parra V
    J Clin Psychiatry; 1996 Sep; 57(9):387-9. PubMed ID: 9746444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of secondary depression in schizophrenia.
    Becker RE; Colliver JA; Verhulst SJ
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):4-8. PubMed ID: 4055721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Winter depression responds to an open trial of tranylcypromine.
    Dilsaver SC; Jaeckle RS
    J Clin Psychiatry; 1990 Aug; 51(8):326-9. PubMed ID: 2199430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotional withdrawal, CT abnormalities and drug response in late life depression.
    Altamura AC; Bassetti R; Santini A; Frisoni GB; Mundo E
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):349-54. PubMed ID: 14751432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of fluoxetine on symptoms of insomnia in depressed patients.
    Satterlee WG; Faries D
    Psychopharmacol Bull; 1995; 31(2):227-37. PubMed ID: 7491373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of the efficacy and safety of nomifensine maleate vs. placebo in depressed outpatients.
    Georgia EH
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):43-6. PubMed ID: 6232263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing major depressive disorder I: A psychometric evaluation of the DSM-IV symptom criteria.
    Zimmerman M; McGlinchey JB; Young D; Chelminski I
    J Nerv Ment Dis; 2006 Mar; 194(3):158-63. PubMed ID: 16534432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two depression rating instruments in Nigerian patients.
    Okulate GT; Jones OB
    Niger Postgrad Med J; 2002 Jun; 9(2):74-8. PubMed ID: 12163877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.
    Mendels J; Kiev A; Fabre LF
    Depress Anxiety; 1999; 9(2):54-60. PubMed ID: 10207659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in inpatients with major depression.
    Zetin M; Sklansky GJ; Cramer M
    J Clin Psychiatry; 1984 Jun; 45(6):257-9. PubMed ID: 6144672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.